PetCaseFinder

Peer-reviewed veterinary case report

How to tell skin vs. under-skin mast cell tumors in dogs

By Itoh, Teruo et al.·Published in Open veterinary journal·2024·Aoba Animal Hospital, Japan·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Clinical differentiation of cutaneous and subcutaneous mast cell tumors in dogs: A pilot study.

Species:
dog

Plain-English summary

A dog with a skin tumor was examined to determine whether it was a cutaneous mast cell tumor (cMCT) or a subcutaneous mast cell tumor (scMCT). The key difference noticed was hair loss on the surface of the tumor; all cMCTs had significant hair loss, while scMCTs did not. By using this visual cue, veterinarians were able to accurately classify most tumors before surgery, which can help in planning the best treatment approach. This method showed a high agreement with laboratory results, making it a useful tool for pet owners and vets alike.

People also search for: dog skin tumor hair loss · mast cell tumor treatment in dogs · how to tell if my dog's tumor is cancerous

Abstract

BACKGROUND: Canine mast cell tumors (MCT) in the skin are classified into cutaneous MCT (cMCT) and subcutaneous MCT (scMCT) types, which exhibit different clinical behaviors. Although these types have been classified only by histology, preoperative differentiation is important for proper surgical planning. AIM: To examine the accuracy of differentiating these types based on the gross features before surgery. METHODS: Gross photographic and histologic features of 52 MCTs (2014-2022) were retrospectively compared between cMCTs and scMCTs. Based on these results, we grossly classified an additional 25 MCTs (2007-2013) into two forms using photographic observations. These observations were then compared with the results of histological classification performed by a blinded pathologist. RESULTS: The most notable difference between the two forms was hair loss on the tumor surface. Hair loss was prominent in all 36 cMCTs but minimal or absent in all 16 scMCTs. Histologically, only the cMCT showed prominent follicular reduction due to MCT infiltration. Using the hair loss feature, we classified an additional 25 MCTs: 15 cMCTs, 7 scMCTs, and 3 unclassifiable cases with overlapping features. Agreement with histological classification was 80% (12/15) for cMCT and 100% (7/7) for scMCT. Among the unclassifiable cases, one was cMCT, and two were scMCT. Large tumors (3.5-10.5 cm) were found in two of the three unclassifiable cases and in all three cases without agreement. CONCLUSION: Hair loss on the tumor surface is a distinct feature of cMCT that enables accurate visual differentiation from scMCT, except for some large MCTs. This may assist in surgical planning, specifically for sc-MCT.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/39737017/